Novo Nordisk stock jumped Monday after the FDA approved the company's obesity drug, Wegovy, as a treatment for MASH.

Investors eyed risks around a high-stakes US-Ukraine meeting, kicking off a week dominated by a Federal Reserve speech that ...

Wall Street is holding near its records. The S&P 500 was basically flat Monday, coming off its first loss after setting an ...

Canada's main stock index opened lower on Monday as investors reined in big bets, kicking off a busy week featuring Ukraine ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

The minutes from the July Fed meeting will be released Wednesday, while Chair Powell will deliver a key speech at Jackson ...